Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Clin Exp Dermatol ; 47(2): 282-288, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34342883

ABSTRACT

BACKGROUND: Although melanoma differentiation associated (MDA)-5 autoantibodies have been widely explored in dermatomyositis (DM), most studies have relied on MDA-5 autoantibody testing performed in research settings, rather than the now-available commercial laboratory tests. AIM: To characterize the clinical and histopathological data in patients with DM and circulating MDA-5 autoantibodies, as defined by commercially available testing. METHODS: This was a retrospective review of patients with DM who underwent MDA-5 antibody testing. All available skin biopsy slides were reviewed. RESULTS: Cutaneous features more prevalent in MDA-5-positive DM included Raynaud phenomenon (RP) (P < 0.001), cutaneous ulcerations (P = 0.01), mechanic hands (P < 0.02), palmar papules (P < 0.01), oral ulcers (P = 0.024) and alopecia (P = 0.03). Joint and pulmonary involvement were more common in patients with MDA-5-positive DM (both P < 0.001) as was dysphagia (P < 0.01). Myopathy (P = 0.4) and malignancy (P = 0.34) were not statistically different between the cohorts. Vasculopathy was more common in MDA-5-positive DM (P < 0.01), while spongiosis was less common (P < 0.02). CONCLUSION: This study not only confirms some known associations between disease manifestations and MDA-5 autoantibody status, as determined by commercially available tests, but also identifies new associations, including RP and dysphagia.


Subject(s)
Autoantibodies/blood , Dermatomyositis/pathology , Interferon-Induced Helicase, IFIH1/immunology , Skin/pathology , Biopsy , Deglutition Disorders/complications , Dermatomyositis/complications , Dermatomyositis/immunology , Female , Humans , Male , Raynaud Disease/complications , Retrospective Studies
2.
Alcohol Alcohol ; 54(2): 173-176, 2019 Mar 01.
Article in English | MEDLINE | ID: mdl-30796774

ABSTRACT

AIMS: The study aims to examine how therapists trained in motivational interviewing (MI) respond to resistance and whether this has an impact on subsequent client speech. METHODS: Fifty recorded Motivational Enhancement Therapy sessions were examined using a sequential behavioural coding method for speech. Client counter-change talk formed the baseline for coding and categorizing subsequent therapist speech and the following client speech. Transitional analysis identified the probable occurrence of specific therapist and client utterances at each stage. RESULTS: Following client expressed resistance or counter-change talk, MI consistent therapist utterances were most commonly observed. A moderate to strong predictive relationship was found between MI-consistent therapist speech and subsequent client change talk. A moderate predictive relationship was found between therapist MI-consistent behaviours and client ambivalence. A moderate to strong predictive relationship was found between MI-inconsistent therapist speech and subsequent client counter-change talk and a weak negative predictive relationship was found between MI-inconsistent therapist speech and client expressed ambivalence. CONCLUSIONS: In the face of initial expressed resistance to change, MI-consistent therapist speech appears to increase subsequent client utterances regarding intentions to change drinking behaviour.


Subject(s)
Alcohol Drinking/therapy , Motivational Interviewing/statistics & numerical data , Pragmatic Clinical Trials as Topic/statistics & numerical data , Professional-Patient Relations , Speech , Humans , Motivation
4.
Oral Dis ; 14(6): 529-32, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18266840

ABSTRACT

OBJECTIVE: To review a series of patients with sore, burning mouth treated with alpha-lipoic acid between 2000 and May 2006 and subjectively evaluate improvement in symptoms. DESIGN: Retrospective review of medical records of 195 consecutive patients who sought treatment for sore, burning mouth. Treatment of 47 patients was a prescription/recommendation for alpha-lipoic acid. Of these patients, 35 were available for follow-up. SETTING: Tertiary care academic medical center. SUBJECTS: Ambulatory patients given prescription /recommendation for alpha-lipoic acid 600 mg per day, in divided doses. MAIN OUTCOME MEASURE: Reported improvement in symptoms documented in medical records and at follow-up (visits or telephone interviews). RESULTS: Thirty-one of the 35 patients (66% of all 47) actually took alpha-lipoic acid as recommended. No patient reported a complete alleviation of symptoms. Six (19%) of these 31 patients felt mostly better, five (16%) felt somewhat better, and 14 (45%) reported no difference. Two patients (7%) reported a worsening of symptoms and four (13%) did not know whether there had been improvement. CONCLUSION: Eleven of 31 patients (35%) reported benefit from taking alpha-lipoic acid. Because we examined only a small number of patients and relied on a subjective outcome assessment, further larger studies using a prospective, randomized, controlled, and double-blind structure are warranted.


Subject(s)
Antioxidants/therapeutic use , Burning Mouth Syndrome/drug therapy , Thioctic Acid/therapeutic use , Vitamin B Complex/therapeutic use , Adult , Aged , Aged, 80 and over , Antioxidants/administration & dosage , Attitude to Health , Cohort Studies , Female , Follow-Up Studies , Humans , Lip Diseases/drug therapy , Male , Middle Aged , Palate/drug effects , Patient Satisfaction , Retrospective Studies , Taste Disorders/drug therapy , Thioctic Acid/administration & dosage , Tongue Diseases/drug therapy , Treatment Outcome , Vitamin B Complex/administration & dosage , Xerostomia/drug therapy
7.
J Am Acad Dermatol ; 42(5 Pt 1): 776-83, 2000 May.
Article in English | MEDLINE | ID: mdl-10775853

ABSTRACT

BACKGROUND: Telemedicine has the potential to revolutionize the delivery of dermatologic care to underserved areas. OBJECTIVE: Our purpose was to compare diagnoses from two types of dermatology consultations: telemedicine using store-and-forward (SAF) technology, and traditional face-to-face (FTF) office visits. METHODS: Skin conditions were imaged with a consumer-grade digital camera. A standardized template was used to collect historical data. Information was stored in a secured database for access by 2 or 3 board-certified dermatologists. Results from the FTF visit were used to assess the accuracy of the SAF diagnoses. RESULTS: A total of 106 dermatologic conditions in 92 patients were included. Concordance between FTF and SAF diagnoses was high, ranging from 81% to 89% for all 3 dermatologists. Clinically relevant disagreement occurred in only 4% to 8% of cases. Remaining disagreements did not affect patient care. Diagnostic confidence and image quality affected agreement. When cases of high confidence were analyzed separately, agreement increased to 88% to 100%. This increase was substantiated by means of a chi-square test between the high confidence and low confidence groups, which demonstrated statistical significance (P <. 005) for all dermatologists. Similarly, when cases of above average image quality were considered, agreement increased to 84% to 98%. Again this difference was substantiated by means of a chi-square test between adequate and poor images, with statistical significance for two dermatologists (P <.001). Accuracy was comparable between disease types with the exception of benign neoplasms, which demonstrated agreement of 22% to 46%. CONCLUSION: These data support the use of existing digital technology to construct an accurate SAF teledermatology system. The inexpensive camera and widely available computer equipment make this an extremely affordable system. Furthermore, participating dermatologists appear well aware of system limitations, as reflected in the increased agreement for high confidence cases. Additional investigation of the accuracy of teledermatology for benign neoplasms is warranted.


Subject(s)
Remote Consultation , Skin Diseases/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged
8.
Mayo Clin Proc ; 74(3): 223-8, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10089989

ABSTRACT

OBJECTIVE: To review a series of patients with a burning or sore mouth for elucidation of associated conditions and treatment outcome. MATERIAL AND METHODS: We retrospectively studied 70 consecutive patients with a burning or sore mouth who were encountered at a tertiary-care center between 1979 and 1992. Clinical and laboratory findings were summarized, and follow-up data were analyzed. RESULTS: The study cohort of 56 women and 14 men had a mean age of 59 years. They had had a burning or sore mouth for a mean duration of 2.5 years. Multiple etiologic factors for the burning or sore mouth were present in 37% of the study subjects. The most frequently associated conditions were psychiatric disease (30%), xerostomia (24%), geographic tongue (24%), nutritional deficiencies (21%), and allergic contact stomatitis (13%). With a treatment course tailored to the suspected causal factor, 72% of the patients who had follow-up reported improvement. CONCLUSION: With a directed investigation, one or more causes could be identified in most patients who had a burning or sore mouth. Successful management of these symptoms was possible in a majority of the patients.


Subject(s)
Stomatitis , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Stomatitis/diagnosis , Stomatitis/etiology , Stomatitis/therapy , Treatment Outcome
9.
Mayo Clin Proc ; 74(1): 68-72, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9987537

ABSTRACT

Four infectious diseases that are associated with high rates of morbidity and mortality are Rocky Mountain spotted fever, meningococcal disease, staphylococcal toxic shock syndrome, and streptococcal toxic shock syndrome. These diseases necessitate a timely diagnosis and treatment, which may be facilitated by recognition of the characteristic cutaneous findings. Herein the clinical manifestations, diagnosis, and management are presented, with emphasis on the dermatologic signs of each disease. A dermatology consultation can be valuable, but all physicians should be familiar with the cutaneous findings of these potentially life-threatening diseases.


Subject(s)
Exanthema/microbiology , Meningococcal Infections/diagnosis , Rocky Mountain Spotted Fever/diagnosis , Shock, Septic/diagnosis , Staphylococcal Infections/diagnosis , Streptococcal Infections/diagnosis , Diagnosis, Differential , Humans , Meningococcal Infections/complications , Rocky Mountain Spotted Fever/complications , Shock, Septic/complications , Staphylococcal Infections/complications , Staphylococcus aureus , Streptococcal Infections/complications , Streptococcus pyogenes
10.
J Am Acad Dermatol ; 37(5 Pt 2): 855-9, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9366852

ABSTRACT

Skin necrosis is a rare complication of subcutaneous heparin therapy that usually occurs at injection sites. It occasionally accompanies the heparin-associated thrombocytopenia and thrombosis syndrome. We describe a patient with the antiphospholipid syndrome who had skin necrosis develop from low-molecular weight heparin therapy at sites distant from injection sites.


Subject(s)
Anticoagulants/adverse effects , Antiphospholipid Syndrome/complications , Heparin, Low-Molecular-Weight/adverse effects , Skin Diseases/chemically induced , Skin/pathology , Adult , Antiphospholipid Syndrome/therapy , Humans , Male , Necrosis , Pulmonary Embolism/complications , Pulmonary Embolism/drug therapy , Thrombophlebitis/complications , Thrombophlebitis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...